{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:51:26Z","timestamp":1769799086889,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam","award":["196\/2023\/H\u0110-\u0110HYD"],"award-info":[{"award-number":["196\/2023\/H\u0110-\u0110HYD"]}]},{"name":"University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam","award":["196\/2023\/H\u0110-\u0110HYD"],"award-info":[{"award-number":["196\/2023\/H\u0110-\u0110HYD"]}]},{"name":"University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam","award":["196\/2023\/H\u0110-\u0110HYD"],"award-info":[{"award-number":["196\/2023\/H\u0110-\u0110HYD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00840-9","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:53:55Z","timestamp":1753948435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of LRRK2 R1628P variant with Parkinson\u2019s disease in Kinh Vietnamese: a cross-sectional study"],"prefix":"10.1007","volume":"26","author":[{"given":"Minh Duc","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai Ngoc","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linh Hoang Gia","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao Phuong","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"840_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066. https:\/\/doi.org\/10.1016\/S0140-6736(09)60492-X","journal-title":"Lancet"},{"key":"840_CR2","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1002\/ana.10487","volume":"53","author":"TT Warner","year":"2003","unstructured":"Warner TT, Schapira AHV (2003) Genetic and environmental factors in the cause of parkinson\u2019s disease. Ann Neurol 53:S16\u2013S25. https:\/\/doi.org\/10.1002\/ana.10487","journal-title":"Ann Neurol"},{"key":"840_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u0131\u0301z","year":"2004","unstructured":"Pais\u00e1n-Ru\u0131\u0301z C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-Linked parkinson\u2019s disease. Neuron 44:595\u2013600. https:\/\/doi.org\/10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"840_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause Autosomal-Dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"},{"key":"840_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata IF, Wedemeyer WJ, Farrer MJ et al (2006) LRRK2 in parkinson\u2019s disease: protein domains and functional insights. Trends Neurosci 29:286\u2013293. https:\/\/doi.org\/10.1016\/j.tins.2006.03.006","journal-title":"Trends Neurosci"},{"key":"840_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in parkinson\u2019s disease. Nat Rev Neurosci 11:791\u2013797. https:\/\/doi.org\/10.1038\/nrn2935","journal-title":"Nat Rev Neurosci"},{"key":"840_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-019-0716-4","volume":"7","author":"JH Lee","year":"2019","unstructured":"Lee JH, Han J, Kim H et al (2019) Parkinson\u2019s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. Acta Neuropathol Commun 7:68. https:\/\/doi.org\/10.1186\/s40478-019-0716-4","journal-title":"Acta Neuropathol Commun"},{"key":"840_CR8","doi-asserted-by":"publisher","first-page":"13138","DOI":"10.1523\/JNEUROSCI.1737-10.2010","volume":"30","author":"C-H Lin","year":"2010","unstructured":"Lin C-H, Tsai P-I, Wu R-M, Chien C-T (2010) LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of Tau by recruiting autoactivated GSK3\u03b2. J Neurosci 30:13138\u201313149. https:\/\/doi.org\/10.1523\/JNEUROSCI.1737-10.2010","journal-title":"J Neurosci"},{"key":"840_CR9","doi-asserted-by":"publisher","first-page":"109864","DOI":"10.1016\/j.celrep.2021.109864","volume":"37","author":"J Walter","year":"2021","unstructured":"Walter J, Bolognin S, Poovathingal SK et al (2021) The Parkinson\u2019s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1. Cell Rep 37:109864. https:\/\/doi.org\/10.1016\/j.celrep.2021.109864","journal-title":"Cell Rep"},{"key":"840_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","volume":"16","author":"L Correia Guedes","year":"2010","unstructured":"Correia Guedes L, Ferreira JJ, Rosa MM et al (2010) Worldwide frequency of G2019S LRRK2 mutation in parkinson\u2019s disease: A systematic review. Parkinsonism Relat Disord 16:237\u2013242. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.11.004","journal-title":"Parkinsonism Relat Disord"},{"key":"840_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ana.21405","volume":"64","author":"OA Ross","year":"2008","unstructured":"Ross OA, Wu Y-R, Lee M-C et al (2008) Analysis of Lrrk2 R1628P as a risk factor for parkinson\u2019s disease. Ann Neurol 64:88\u201392. https:\/\/doi.org\/10.1002\/ana.21405","journal-title":"Ann Neurol"},{"key":"840_CR12","doi-asserted-by":"publisher","first-page":"35171","DOI":"10.1038\/srep35171","volume":"6","author":"P Zhang","year":"2016","unstructured":"Zhang P, Wang Q, Jiao F et al (2016) Association of LRRK2 R1628P variant with parkinson\u2019s disease in ethnic Han-Chinese and subgroup population. Sci Rep 6:35171. https:\/\/doi.org\/10.1038\/srep35171","journal-title":"Sci Rep"},{"key":"840_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10048-008-0140-6","volume":"9","author":"C-S Lu","year":"2008","unstructured":"Lu C-S, Wu-Chou Y-H, van Doeselaar M et al (2008) The LRRK2 Arg1628Pro variant is a risk factor for parkinson\u2019s disease in the Chinese population. Neurogenetics 9:271\u2013276. https:\/\/doi.org\/10.1007\/s10048-008-0140-6","journal-title":"Neurogenetics"},{"key":"840_CR14","doi-asserted-by":"publisher","first-page":"e2950","DOI":"10.1002\/brb3.2950","volume":"13","author":"MD Do","year":"2023","unstructured":"Do MD, Tran TN, Luong AB et al (2023) Clinical and genetic analysis of Vietnamese patients diagnosed with early-onset parkinson\u2019s disease. Brain Behav 13:e2950. https:\/\/doi.org\/10.1002\/brb3.2950","journal-title":"Brain Behav"},{"key":"840_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M et al (2001) DbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308\u2013311. https:\/\/doi.org\/10.1093\/nar\/29.1.308","journal-title":"Nucleic Acids Res"},{"key":"840_CR16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"840_CR17","doi-asserted-by":"publisher","unstructured":"Le LHG, Mai\u00a0TP (2025) Establishing ASO PCR protocol for identifying R1628P variant in LRRK2 gene. Vietnam Med J 71:201\u2013204.\u00a0https:\/\/doi.org\/10.51298\/vmj.v547i2.12990","DOI":"10.51298\/vmj.v547i2.12990"},{"key":"840_CR18","doi-asserted-by":"publisher","first-page":"7132494","DOI":"10.1155\/2019\/7132494","volume":"2019","author":"P-T Mai","year":"2019","unstructured":"Mai P-T, Le D-T, Nguyen T-T et al (2019) Novel GDAP1 mutation in a Vietnamese family with Charcot-Marie-Tooth disease. Biomed Res Int 2019:7132494. https:\/\/doi.org\/10.1155\/2019\/7132494","journal-title":"Biomed Res Int"},{"key":"840_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ijlh.13345","volume":"43","author":"MD Do","year":"2021","unstructured":"Do MD, Pham DV, Le LP et al (2021) Recurrent PROC and novel PROS1 mutations in Vietnamese patients diagnosed with idiopathic deep venous thrombosis. Int J Lab Hematol 43:266\u2013272. https:\/\/doi.org\/10.1111\/ijlh.13345","journal-title":"Int J Lab Hematol"},{"key":"840_CR20","doi-asserted-by":"publisher","unstructured":"Thao MP, Tuan PVA, Linh LGH et al (2018) Association of HLA-B\u221738:02 with antithyroid drug-induced agranulocytosis in Kinh Vietnamese patients. Int J Endocrinol 2018:7965346. https:\/\/doi.org\/10.1155\/2018\/7965346","DOI":"10.1155\/2018\/7965346"},{"key":"840_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13075-020-02273-1","volume":"22","author":"MD Do","year":"2020","unstructured":"Do MD, Mai TP, Do AD et al (2020) Risk factors for cutaneous reactions to allopurinol in Kinh vietnamese: results from a case-control study. Arthritis Res Therapy 22:182. https:\/\/doi.org\/10.1186\/s13075-020-02273-1","journal-title":"Arthritis Res Therapy"},{"key":"840_CR22","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/MCB.00660-20","volume":"41","author":"A Usmani","year":"2021","unstructured":"Usmani A, Shavarebi F, Hiniker A (2021) The cell biology of LRRK2 in parkinson\u2019s disease. Mol Cell Biol 41:e00660\u2013e00620. https:\/\/doi.org\/10.1128\/MCB.00660-20","journal-title":"Mol Cell Biol"},{"key":"840_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui Q, Ni H, Li D et al (2018) The role of LRRK2 in neurodegeneration of Parkinson disease. Curr Neuropharmacol 16:1348\u20131357. https:\/\/doi.org\/10.2174\/1570159X16666180222165418","journal-title":"Curr Neuropharmacol"},{"key":"840_CR24","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.bbamcr.2017.09.001","volume":"1864","author":"J-H Yoon","year":"2017","unstructured":"Yoon J-H, Mo J-S, Kim M-Y et al (2017) LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death. Biochim Biophys Acta (BBA) Mol Cell Res 1864:2356\u20132368. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.09.001","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"840_CR25","doi-asserted-by":"publisher","unstructured":"Y S, J M, P Z, et al (2016) Parkinson-Related LRRK2 mutation R1628P enables Cdk5 phosphorylation of LRRK2 and upregulates its kinase activity. PloS one 11:. https:\/\/doi.org\/10.1371\/journal.pone.0149739","DOI":"10.1371\/journal.pone.0149739"},{"key":"840_CR26","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1073\/pnas.1312701111","volume":"111","author":"K Muda","year":"2014","unstructured":"Muda K, Bertinetti D, Gesellchen F et al (2014) Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3. Proc Natl Acad Sci U S A 111:E34\u201343. https:\/\/doi.org\/10.1073\/pnas.1312701111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"840_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddl471","volume":"16","author":"AB West","year":"2007","unstructured":"West AB, Moore DJ, Choi C et al (2007) Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 16:223\u2013232. https:\/\/doi.org\/10.1093\/hmg\/ddl471","journal-title":"Hum Mol Genet"},{"key":"840_CR28","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry AG, Aghamohammadzadeh S, Samaroo H et al (2015) Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet 24:6013\u20136028. https:\/\/doi.org\/10.1093\/hmg\/ddv314","journal-title":"Hum Mol Genet"},{"key":"840_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-025-00896-2","volume":"11","author":"LM Lange","year":"2025","unstructured":"Lange LM, Levine K, Fox SH et al (2025) The LRRK2 p.L1795F variant causes parkinson\u2019s disease in the European population. Npj Parkinsons Dis 11:1\u201310. https:\/\/doi.org\/10.1038\/s41531-025-00896-2","journal-title":"Npj Parkinsons Dis"},{"key":"840_CR30","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1042\/BCJ20220161","volume":"479","author":"AF Kalogeropulou","year":"2022","unstructured":"Kalogeropulou AF, Purlyte E, Tonelli F et al (2022) Impact of 100 LRRK2 variants linked to parkinson\u2019s disease on kinase activity and microtubule binding. Biochem J 479:1759\u20131783. https:\/\/doi.org\/10.1042\/BCJ20220161","journal-title":"Biochem J"},{"key":"840_CR31","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1093\/brain\/awh666","volume":"128","author":"D Berg","year":"2005","unstructured":"Berg D, Schweitzer KJ, Leitner P et al (2005) Type and frequency of mutations in the LRRK2 gene in Familial and sporadic parkinson\u2019s disease*. Brain 128:3000\u20133011. https:\/\/doi.org\/10.1093\/brain\/awh666","journal-title":"Brain"},{"key":"840_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/sj.ejhg.5201539","volume":"14","author":"A Di Fonzo","year":"2006","unstructured":"Di Fonzo A, Tassorelli C, De Mari M et al (2006) Comprehensive analysis of the LRRK2 gene in Sixty families with parkinson\u2019s disease. Eur J Hum Genet 14:322\u2013331. https:\/\/doi.org\/10.1038\/sj.ejhg.5201539","journal-title":"Eur J Hum Genet"},{"key":"840_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.parkreldis.2014.06.013","volume":"20","author":"T Pulkes","year":"2014","unstructured":"Pulkes T, Papsing C, Thakkinstian A et al (2014) Confirmation of the association between LRRK2 R1628P variant and susceptibility to parkinson\u2019s disease in the Thai population. Parkinsonism Relat Disord 20:1018\u20131021. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.06.013","journal-title":"Parkinsonism Relat Disord"},{"key":"840_CR34","doi-asserted-by":"publisher","first-page":"867321","DOI":"10.1155\/2014\/867321","volume":"2014","author":"AA Gopalai","year":"2014","unstructured":"Gopalai AA, Lim S-Y, Chua JY et al (2014) LRRK2 G2385R and R1628P mutations are associated with an increased risk of parkinson\u2019s disease in the Malaysian population. Biomed Res Int 2014:867321. https:\/\/doi.org\/10.1155\/2014\/867321","journal-title":"Biomed Res Int"},{"key":"840_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.parkreldis.2022.05.012","volume":"98","author":"C Simpson","year":"2022","unstructured":"Simpson C, Vinikoor-Imler L, Nassan FL et al (2022) Prevalence of ten LRRK2 variants in parkinson\u2019s disease: A comprehensive review. Parkinsonism Relat Disord 98:103\u2013113. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.012","journal-title":"Parkinsonism Relat Disord"},{"key":"840_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnagi.2019.00013","volume":"11","author":"L Shu","year":"2019","unstructured":"Shu L, Zhang Y, Sun Q et al (2019) A comprehensive analysis of population differences in LRRK2 variant distribution in parkinson\u2019s disease. Front Aging Neurosci 11:13. https:\/\/doi.org\/10.3389\/fnagi.2019.00013","journal-title":"Front Aging Neurosci"},{"key":"840_CR37","doi-asserted-by":"publisher","first-page":"e31653","DOI":"10.1097\/MD.0000000000031653","volume":"101","author":"NQ Tran","year":"2022","unstructured":"Tran NQ, Truong SD, Ma PT et al (2022) Association of KCNJ11 and ABCC8 single-nucleotide polymorphisms with type 2 diabetes mellitus in a Kinh Vietnamese population. Med (Baltim) 101:e31653. https:\/\/doi.org\/10.1097\/MD.0000000000031653","journal-title":"Med (Baltim)"},{"key":"840_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2147\/DMSO.S347830","volume":"15","author":"S Truong","year":"2022","unstructured":"Truong S, Tran NQ, Ma PT et al (2022) Association of ADIPOQ Single-Nucleotide polymorphisms with the two clinical phenotypes type 2 diabetes mellitus and metabolic syndrome in a Kinh Vietnamese population. Diabetes Metab Syndr Obes 15:307\u2013319. https:\/\/doi.org\/10.2147\/DMSO.S347830","journal-title":"Diabetes Metab Syndr Obes"},{"key":"840_CR39","doi-asserted-by":"publisher","first-page":"608948","DOI":"10.3389\/fcvm.2021.608948","volume":"8","author":"TT Tran","year":"2021","unstructured":"Tran TT, Mai TP, Tran HCB et al (2021) Association between AGT M235T and left ventricular mass in Vietnamese patients diagnosed with essential hypertension. Front Cardiovasc Med 8:608948. https:\/\/doi.org\/10.3389\/fcvm.2021.608948","journal-title":"Front Cardiovasc Med"},{"key":"840_CR40","doi-asserted-by":"publisher","first-page":"e34976","DOI":"10.1097\/MD.0000000000034976","volume":"102","author":"DC Tran","year":"2023","unstructured":"Tran DC, Do MD, Le LHG et al (2023) Predictive value of ACE I\/D genetic polymorphism for 12-month all-cause mortality in patients with acute myocardial infarction. Medicine 102:e34976. https:\/\/doi.org\/10.1097\/MD.0000000000034976","journal-title":"Medicine"},{"key":"840_CR41","doi-asserted-by":"publisher","first-page":"e0300273","DOI":"10.1371\/journal.pone.0300273","volume":"19","author":"DC Tran","year":"2024","unstructured":"Tran DC, Le LHG, Thai TT et al (2024) Effect of AGTR1 A1166C genetic polymorphism on coronary artery lesions and mortality in patients with acute myocardial infarction. PLoS ONE 19:e0300273. https:\/\/doi.org\/10.1371\/journal.pone.0300273","journal-title":"PLoS ONE"},{"key":"840_CR42","doi-asserted-by":"publisher","unstructured":"Tran DC, Le LHG, Thai TT et al (2023) Association between ACE I\/D genetic polymorphism and the severity of coronary artery disease in Vietnamese patients with acute myocardial infarction. Front Cardiovasc Med 10. https:\/\/doi.org\/10.3389\/fcvm.2023.1091612","DOI":"10.3389\/fcvm.2023.1091612"},{"key":"840_CR43","doi-asserted-by":"publisher","first-page":"e18526","DOI":"10.1111\/jcmm.18526","volume":"28","author":"TP Mai","year":"2024","unstructured":"Mai TP, Luong BA, Ma PT et al (2024) Genome-wide association and polygenic risk score estimation of type 2 diabetes mellitus in Kinh Vietnamese-A pilot study. J Cell Mol Med 28:e18526. https:\/\/doi.org\/10.1111\/jcmm.18526","journal-title":"J Cell Mol Med"},{"key":"840_CR44","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.parkreldis.2012.05.003","volume":"18","author":"C Wang","year":"2012","unstructured":"Wang C, Cai Y, Zheng Z et al (2012) Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat Disord 18:958\u2013963. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.05.003","journal-title":"Parkinsonism Relat Disord"},{"key":"840_CR45","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396:1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00840-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:05:05Z","timestamp":1769400305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00840-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00840-9","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam (Approval number 1133\/H\u0110\u0110\u0110-\u0110HYD).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}